Muscular Dystrophies: all 550 studies

Page 1 of 6. Open to participants first (89), then studies with results posted, then the rest; newest registration first within each.

• Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy PatientsRecruitingNCT07766980Phase 2
• Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) ExtensionRecruitingNCT07700225
• Duchenne Electronic Health Record StudyRecruitingNCT07609394
• Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)RecruitingNCT07608432Phase 3
• A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 SkippingRecruitingNCT07587242Phase 3
• VirtualPark_PediatricRecruitingNCT07580365Not applicable
• Amino Acids and Exercise in FSHDRecruitingNCT07543016Not applicable
• Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)RecruitingNCT07521930Not applicable
• A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese ChildrenNot yet recruitingNCT07511920
• Muscle Health Measurements Using Electrical Impedance MyographyRecruitingNCT07502989
• PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)RecruitingNCT07429240Phase 1/2
• Registry for Duchenne and Becker Muscular DystrophyRecruitingNCT07402122
• Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic DystrophyRecruitingNCT07362875
• Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic VolunteersRecruitingNCT07321977Not applicable
• Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 SkippingAvailableNCT07250737
• Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne CardiomyopathyRecruitingNCT07172971Phase 1
• Fear of Falling in Muscular DystrophyRecruitingNCT07129954Not applicable
• A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular DystrophyRecruitingNCT07127978
• Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young AdultsRecruitingNCT06998134
• A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type IEnrolling by invitationNCT06926621Phase 2
• DMD Voice: Qualitative Interviews With Patients and CaregiversRecruitingNCT06925269
• Spanish Natural History Study for LAMA2 Muscular DystrophyRecruitingNCT06924125
• Ten Year Follow-up in FSHD: the FOCUS 3 StudyRecruitingNCT06911190
• Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular DystrophyRecruitingNCT06900049Early Phase 1
• Social Cognition in Dystrophinopathies and Neurodevelopmental DisordersNot yet recruitingNCT06874166
• Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle DiseasesRecruitingNCT06833489Not applicable
• Follow-up of NIV At Home in Patients with Duchenne Muscular DystrophyRecruitingNCT06773988
• Respiratory Functions, Thoracoabdominal Movements and Exercise Capacity in Neuromuscular DiseasesRecruitingNCT06756633
• Research on the Relationship Between Scoliosis, Pain, Quality of Life, and Trunk Muscle Compensation Patterns Among Patients with Duchenne Muscular Dystrophy.RecruitingNCT06755138
• Analysis of Motor Performance in Children with Duchene's Muscular DystrophyNot yet recruitingNCT06750042
• Evaluation of Brain Dysfunction in Patients with Duchene Muscular DystrophyNot yet recruitingNCT06732011
• The U.K. NorthStar Clinical NetworkNot yet recruitingNCT06711692
• Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular DiseasesRecruitingNCT06666816
• Effects of Lumbopelvic Stabilization-based Physiotherapy and Rehabilitation Training in Duchenne Muscular DystrophyNot yet recruitingNCT06643923Not applicable
• Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular DystrophyRecruitingNCT06641895Early Phase 1
• Development of a Registry to Assess Natural History in Duchenne Muscular DystrophyNot yet recruitingNCT06579859
• Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMITRecruitingNCT06564974
• Applying the Pathways and Resources for Engagement and Participation Protocol Among People With Muscles DystrophiesNot yet recruitingNCT06540365Not applicable
• FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare DiseasesRecruitingNCT06539169
• Effect of Captopril on GLS in Duchenne MyodystrophyRecruitingNCT06485661Early Phase 1
• Psychoeducation Program for Parents of Children with Duchenne Muscular DystrophyEnrolling by invitationNCT06412328Not applicable
• The Role of Muscle Ultrasound in Assessment of Sample of Patients With Limb-girdle Muscular DystrophyNot yet recruitingNCT06399770
• Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]RecruitingNCT06378203Not applicable
• phenotypeS in Non Ambulant Duchenne Muscular DystrophyRecruitingNCT06366815
• Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.Enrolling by invitationNCT06363526Not applicable
• Natural History Study of Children With LAMA2-related DystrophiesRecruitingNCT06354790
• Characterization of DupEx2 Duchenne Muscular DystrophyRecruitingNCT06337669
• Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular DystrophyNot yet recruitingNCT06328725Phase 1/2
• Vasodilator and Exercise Study for DMD (VASO-REx)RecruitingNCT06290713Phase 2
• Magnetic Resonance Imaging and Ultrasound Comparison With Load EvaluationRecruitingNCT06227182
• Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular DystrophyRecruitingNCT06224660Phase 1
• A 5-year Natural History Study in LAMA2-related Muscular Dystrophy and SELENON-related Myopathy.RecruitingNCT06132750
• Telerehabilitation-based Motor Imagery Training in Children With Duchenne Muscular DystrophyNot yet recruitingNCT06109103Not applicable
• Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)RecruitingNCT06094205Not applicable
• Unraveling Metabolic Involvement in Facioscapulohumeral Dystrophy Through MetabolomicsNot yet recruitingNCT06086548
• Long-Term Development of Muscular Dystrophy Outcome AssessmentsRecruitingNCT05989620
• Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next StudyRecruitingNCT05982119Not applicable
• Effect of Kinesiology Taping on Head and Trunk Control in Children With Duchenne Muscular DystrophyRecruitingNCT05967793Not applicable
• Clinical and Biochemical Features for the Identification of Dominant CalpainopathiesEnrolling by invitationNCT05956132
• Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2Enrolling by invitationNCT05854433
• Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular DystrophyRecruitingNCT05753462Phase 1/2
• Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement DisordersRecruitingNCT05726591Not applicable
• Feasibility of the BrainGate2 Neural Interface System in Persons With TetraplegiaRecruitingNCT05724173Not applicable
• Follow-up Study on Female Carriers With DMD Gene VariantsEnrolling by invitationNCT05715957
• Nomad P-KAFO StudyRecruitingNCT05644522Not applicable
• Motor Imagery on Children With DMD on Gait and Balance FunctionsRecruitingNCT05601986Not applicable
• iBCI Optimization for Veterans With ParalysisNot yet recruitingNCT05470478Not applicable
• Once Weekly Infant Corticosteroid Trial for DMDRecruitingNCT05412394Phase 4
• Modifying Factors in Striated Muscle LaminopathiesRecruitingNCT05394506Not applicable
• Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal CohortRecruitingNCT05295277
• Correlation Between Functional Capacity and Functional Capability in Duchenne Muscular DystrophyRecruitingNCT05249361
• Investigational Use of Neuromuscular UltrasoundRecruitingNCT05237973
• The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMDRecruitingNCT05066633Phase 3
• Motor Parameters in Patients With Limb Girdle Muscular DystrophyRecruitingNCT04772027
• A Registered Cohort Study on FSHD1RecruitingNCT04369209
• A Registered Cohort Study on Duchenne Muscular DystrophyRecruitingNCT04012671
• Global FKRP RegistryRecruitingNCT04001595
• The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient RegistryRecruitingNCT04001582
• ECoG BMI for Motor and Speech ControlRecruitingNCT03698149Not applicable
• Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac ArrhythmiasEnrolling by invitationNCT02413450
• The Duchenne RegistryRecruitingNCT02069756
• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT01793168
• Congenital Muscle Disease Study of Patient and Family Reported Medical InformationRecruitingNCT01403402
• BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With TetraplegiaRecruitingNCT00912041Not applicable
• Molecular Analysis of Patients With Neuromuscular DiseaseRecruitingNCT00390104
• Clinical Trial Readiness for the DystroglycanopathiesRecruitingNCT00313677
• Genetics of Cardiovascular and Neuromuscular DiseaseRecruitingNCT00138931
• Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy RegistryRecruitingNCT00082108
• Study of Inherited Neurological DisordersRecruitingNCT00004568
• Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE)CompletedNCT06304064Phase 2Results posted
• Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)TerminatedNCT05397470Phase 3Results posted
• A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)CompletedNCT05185622Phase 2Results posted
• A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)CompletedNCT05166109Phase 2Results posted
• A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)CompletedNCT05096221Phase 3Results posted
• Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53)CompletedNCT04956289Phase 2Results posted
• Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC IntervalCompletedNCT04821063Phase 1Results posted
• Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMDTerminatedNCT04632940Phase 3Results posted
• Open-label Extension of the HOPE-2 TrialActive, not recruitingNCT04428476Phase 2Results posted
• Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)TerminatedNCT04371666Phase 3Results posted
• A Study to Evaluate the Safety and Pharmacokinetics of Ataluren in Participants From ≥6 Months to <2 Years of Age With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)CompletedNCT04336826Phase 2Results posted

← Muscular Dystrophies overview